(Q36554146)

14 August 2017

1 reference

title

Advances in the management of gout and hyperuricaemia (English)

1 reference

14 August 2017

Hoskison TK

1

1 reference

14 August 2017

Wortmann RL

series ordinal

2

1 reference

14 August 2017

publication date

1 July 2006

1 reference

Scandinavian Journal of Rheumatology

14 August 2017

published in

1 reference

14 August 2017

volume

35

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

251-260

1 reference

Quality of care indicators for gout management

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the field

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

21 January 2018

The management of gout

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Investigation and management of gout in the young and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Update on colchicine and its mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

A literature review of the epidemiology and treatment of acute gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Does colchicine work? The results of the first controlled study in acute gout.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Imaging of tophaceous gout: computed tomography provides specific images compared with magnetic resonance imaging and ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Colchicine induced rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Systemic steroid therapy for acute gout: a clinical trial and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Gout: can management be improved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

How well have diagnostic tests and therapies for gout been evaluated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Colchicine myopathy and neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Gout in the elderly. Clinical presentation and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Arthritis Associated with Apatite Crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Crystal-induced arthritis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Long-term efficacy of hyperuricaemia treatment in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Gout: on the brink of novel therapeutic options for an ancient disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Recent advances in the management of gout and hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Alcohol intake and risk of incident gout in men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Regulation of renal urate excretion: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740600855825

10.1080/03009740600855825

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference